27
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Lack of Correlation Between Clinical Characteristics and Serum Soluble Fas Ligand Levels in Patients with Multiple Myeloma

, , , , , , , , , , , , , & show all
Pages 351-356 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mine Hekimgil, Seçkin Çağirgan, Mustafa Pehlivan, Başak Doğanavşargil, Murat Tombuloğlu & Saliha Soydan. (2006) Immunohistochemical detection of CD 95 (Fas) & Fas ligand (Fas-L) in plasma cells of multiple myeloma and its correlation with survival. Leukemia & Lymphoma 47:2, pages 271-280.
Read now
Quan Chen, Subrata Ray, Mohamad A. Hussein, Gordan Srkalovic & Alexandru Almasan. (2003) Role of Apo2L/TRAIL and Bcl-2-family Proteins in Apoptosis of Multiple Myeloma. Leukemia & Lymphoma 44:7, pages 1209-1214.
Read now

Articles from other publishers (2)

Michael G. Alexandrakis, Constantina A. Pappa, Anna Kolovou, Stavroula Kyriakaki, Rodanthi Vyzoukaki, Maria Devetzoglou & George Tsirakis. (2014) Circulating levels of soluble Fas ligand reflect disease progression in multiple myeloma. Medical Oncology 31:5.
Crossref
S. Holdenrieder & P. Stieber. (2004) Apoptotic markers in cancer. Clinical Biochemistry 37:7, pages 605-617.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.